Evaluation of a new, fully automated immunoassay for detection of HTLV‐I and HTLV‐II antibodies
Authors:
- 18 January 2008
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 80 (3) , 484-493
Abstract
Screening blood donations for human T‐lymphotropic virus types I and II (HTLV‐I/II) continues to be important in protecting the safety of blood products and controlling the global spread of these retroviruses. We have developed a fully automated, third generation chemiluminescent immunoassay, ARCHITECT rHTLV‐I/II, for detection of antibodies to HTLV‐I/II. The assay utilizes recombinant proteins and synthetic peptides and is configured in a double antigen sandwich assay format. Specificity of the assay was 99.98% (9,254/9,256, 95% CI = 99.92–100%) with the negative specimens from the general population including blood donors, hospital patients and pregnant women from the US, Japan and Nicaragua. The assay demonstrated 100% sensitivity by detecting 498 specimens from individuals infected with HTLV‐I (n = 385) and HTLV‐II (n = 113). ARCHITECT rHTLV‐I/II results were in complete agreement with the Murex HTLV‐I/II reference assay and 99.7% agreement with the Genelabs HTLV Blot 2.4 confirmatory assay. Analytical sensitivity of the assay was equivalent to Murex HTLV‐I/II assay based on end point dilutions. Furthermore, using a panel of 397 specimens from Japan, the ARCHITECT rHTLV‐I/II assay exhibited distinct discrimination between the antibody negative (Delta Value = −7.6) and positive (Delta Value = 7.6) populations. Based on the excellent specificity and sensitivity, the new ARCHITECT rHTLV‐I/II assay should be an effective test for the diagnosis of HTLV‐I/II infection and also for blood donor screening. J. Med. Virol. 80:484–493, 2008.Keywords
This publication has 46 references indexed in Scilit:
- Human T-Cell Lymphotropic Virus Type 3: Complete Nucleotide Sequence and Characterization of the Human Tax3 ProteinJournal of Virology, 2006
- High Endemicity of Human T-Cell Lymphotropic Virus Type 1 Among Pregnant Women in PeruJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Ancient Origin and Molecular Features of the Novel Human T-Lymphotropic Virus Type 3 Revealed by Complete Genome AnalysisJournal of Virology, 2006
- Combination HCV core antigen and antibody assay on a fully automated chemiluminescence analyzerTransfusion, 2003
- Seven Human Immunodeficiency Virus (HIV) Antigen-Antibody Combination Assays: Evaluation of HIV Seroconversion Sensitivity and Subtype DetectionJournal of Clinical Microbiology, 2001
- Human T Lymphotropic Virus Type II (HTLV-II): Epidemiology, Molecular Properties, and Clinical Features of InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITYThe Lancet, 1986
- ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESISThe Lancet, 1985
- Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.Proceedings of the National Academy of Sciences, 1982
- Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphomaProceedings of the National Academy of Sciences, 1980